These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 26921751)

  • 21. Targeted siRNA silencing of indoleamine 2, 3-dioxygenase in antigen-presenting cells using mannose-conjugated liposomes: a novel strategy for treatment of melanoma.
    Chen D; Koropatnick J; Jiang N; Zheng X; Zhang X; Wang H; Yuan K; Siu KS; Shunnar A; Way C; Min WP
    J Immunother; 2014; 37(2):123-34. PubMed ID: 24509175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Asymptomatic atopy is associated with increased indoleamine 2,3-dioxygenase activity and interleukin-10 production during seasonal allergen exposure.
    von Bubnoff D; Fimmers R; Bogdanow M; Matz H; Koch S; Bieber T
    Clin Exp Allergy; 2004 Jul; 34(7):1056-63. PubMed ID: 15248850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indoleamine 2,3-dioxygenase is increased in hemodialysis patients and affects immune response to hepatitis B vaccination.
    Eleftheriadis T; Liakopoulos V; Antoniadi G; Stefanidis I; Galaktidou G
    Vaccine; 2011 Mar; 29(12):2242-7. PubMed ID: 21292009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neem leaf glycoprotein overcomes indoleamine 2,3 dioxygenase mediated tolerance in dendritic cells by attenuating hyperactive regulatory T cells in cervical cancer stage IIIB patients.
    Roy S; Barik S; Banerjee S; Bhuniya A; Pal S; Basu P; Biswas J; Goswami S; Chakraborty T; Bose A; Baral R
    Hum Immunol; 2013 Aug; 74(8):1015-23. PubMed ID: 23628394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma indoleamine 2,3-dioxygenase concentration is increased in hemodialysis patients and may contribute to the pathogenesis of coronary heart disease.
    Eleftheriadis T; Antoniadi G; Liakopoulos V; Stefanidis I; Galaktidou G
    Ren Fail; 2012; 34(1):68-72. PubMed ID: 22017594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peritumoral indoleamine 2,3-dioxygenase expression in melanoma: an early marker of resistance to immune control?
    Chevolet I; Speeckaert R; Haspeslagh M; Neyns B; Krüse V; Schreuer M; Van Gele M; Van Geel N; Brochez L
    Br J Dermatol; 2014 Nov; 171(5):987-95. PubMed ID: 24814041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlations of indoleamine 2,3-dioxygenase, interferon-λ3, and anti-HBs antibodies in hemodialysis patients.
    Grzegorzewska AE; Winnicka H; Warchoł W; Mostowska A; Jagodziński PP
    Vaccine; 2018 Jul; 36(30):4454-4461. PubMed ID: 29935858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced indoleamine 2,3-dioxygenase activity in patients with severe sepsis and septic shock.
    Tattevin P; Monnier D; Tribut O; Dulong J; Bescher N; Mourcin F; Uhel F; Le Tulzo Y; Tarte K
    J Infect Dis; 2010 Mar; 201(6):956-66. PubMed ID: 20151841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arachidonic acid and its COX1/2 metabolites inhibit interferon-γ mediated induction of indoleamine-2,3 dioxygenase in THP-1 cells and human monocytes.
    Bassal NK; Hughes BP; Costabile M
    Prostaglandins Leukot Essent Fatty Acids; 2012; 87(4-5):119-26. PubMed ID: 22947424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indoleamine 2,3-dioxygenase depletes tryptophan, activates general control non-derepressible 2 kinase and down-regulates key enzymes involved in fatty acid synthesis in primary human CD4+ T cells.
    Eleftheriadis T; Pissas G; Antoniadi G; Liakopoulos V; Stefanidis I
    Immunology; 2015 Oct; 146(2):292-300. PubMed ID: 26147366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extinguishing maternal immune responses during pregnancy: implications for immunosuppression.
    Mellor AL; Munn DH
    Semin Immunol; 2001 Aug; 13(4):213-8. PubMed ID: 11437628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indoleamine 2,3-dioxygenase in tumor induced tolerance.
    Liu XQ; Wang X
    Chin Med J (Engl); 2009 Dec; 122(24):3072-7. PubMed ID: 20137504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct effects of human glioblastoma immunoregulatory molecules programmed cell death ligand-1 (PDL-1) and indoleamine 2,3-dioxygenase (IDO) on tumour-specific T cell functions.
    Avril T; Saikali S; Vauleon E; Jary A; Hamlat A; De Tayrac M; Mosser J; Quillien V
    J Neuroimmunol; 2010 Aug; 225(1-2):22-33. PubMed ID: 20493562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer.
    Yu J; Du W; Yan F; Wang Y; Li H; Cao S; Yu W; Shen C; Liu J; Ren X
    J Immunol; 2013 Apr; 190(7):3783-97. PubMed ID: 23440412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uveal melanoma expression of indoleamine 2,3-deoxygenase: establishment of an immune privileged environment by tryptophan depletion.
    Chen PW; Mellon JK; Mayhew E; Wang S; He YG; Hogan N; Niederkorn JY
    Exp Eye Res; 2007 Nov; 85(5):617-25. PubMed ID: 17870068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IDO expression by human B lymphocytes in response to T lymphocyte stimuli and TLR engagement is biologically inactive.
    Godin-Ethier J; Hanafi LA; Duvignaud JB; Leclerc D; Lapointe R
    Mol Immunol; 2011 Oct; 49(1-2):253-9. PubMed ID: 21937116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of pregnancy-specific β1-glycoprotein on indoleamine-2,3-dioxygenase activity in human monocytes.
    Zamorina SA; Timganova VP; Bochkova MS; Khramtsov PV; Raev MB
    Dokl Biol Sci; 2016 Jul; 469(1):206-8. PubMed ID: 27595833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma indoleamine 2,3-dioxygenase and arginase type I may contribute to decreased blood T-cell count in hemodialysis patients.
    Eleftheriadis T; Yiannaki E; Antoniadi G; Liakopoulos V; Pissas G; Galaktidou G; Stefanidis I
    Ren Fail; 2012; 34(9):1118-22. PubMed ID: 22897519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of indoleamine 2,3-dioxygenase in human corneal cells as a local immunosuppressive factor.
    Ryu YH; Kim JC
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4148-52. PubMed ID: 17724200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds.
    Di Pucchio T; Danese S; De Cristofaro R; Rutella S
    Expert Opin Ther Pat; 2010 Feb; 20(2):229-50. PubMed ID: 20100004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.